These changes result in a decrease in the protective effects of the ACE2/ANG1–7/MasR axis and favor the detrimental effect of relatively underregulated ANG II activity and possibly leading to a higher incidence of myocardial infarction in appropriately predisposed patients. This evidence concerns the gene ANGPT1 and myocardial infarction.